Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

INXBTC

(INXBTC)

Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
06/20/20241:33AMAlliance NewsAlliance NewsGET READY: CMC Markets, Cordiant, DS Smith, XPS Pensions at 0700 BST
06/20/20241:33AMPR Newswire (US)Envision Energy Launches Advanced 5 MWh Container Battery Energy Storage System with Industry-Leading Safety Standards
06/20/20241:32AMPR Newswire (Canada)More Economical, More Space, More Power - GAC EMZOOM Redefining Innovation on Global SUV Market
06/20/20241:32AMPR Newswire (US)More Economical, More Space, More Power - GAC EMZOOM Redefining Innovation on Global SUV Market
06/20/20241:30AMAlliance NewsAlliance NewsAlliance News UK - start of day
06/20/20241:30AMGlobeNewswire Inc.Sampo plc’s share buybacks 19 June 2024
06/20/20241:30AMGlobeNewswire Inc.OSE Immunotherapeutics présente des données précliniques sur sa plateforme ARNm thérapeutique dans le traitement des maladies auto-immunes et inflammatoires au congrès annuel FOCIS, San Francisco (18 – 21 juin)TG:6OPOSE Immunotherapeutics
06/20/20241:30AMBusiness WireSensorion Announces Upcoming Presentation of Promising SENS-401 Results at the Next International Conference on Cochlear Implants and Other Implantable TechnologiesEU:ALSENSensorion
06/20/20241:30AMGlobeNewswire Inc.OSE Immunotherapeutics présente des données précliniques sur sa plateforme ARNm thérapeutique dans le traitement des maladies auto-immunes et inflammatoires au congrès annuel FOCIS, San Francisco (18 – 21 juin)LSE:0RADOse Immunotherapeutics Sa
06/20/20241:30AMGlobeNewswire Inc.OSE Immunotherapeutics présente des données précliniques sur sa plateforme ARNm thérapeutique dans le traitement des maladies auto-immunes et inflammatoires au congrès annuel FOCIS, San Francisco (18 – 21 juin)EU:OSEOSE Immunotherapeutics
06/20/20241:30AMGlobeNewswire Inc.BGHL (GBP): NAV(s)LSE:BGHSBoussard & Gavaudan Holding Limited
06/20/20241:30AMGlobeNewswire Inc.OSE Immunotherapeutics Presents Preclinical Data on mRNA Therapeutic Platform for the Treatment of Inflammatory and Autoimmune Disorders at the FOCIS Annual Meeting, San Francisco (June 18 – 21)EU:OSEOSE Immunotherapeutics
06/20/20241:30AMGlobeNewswire Inc.BGHL (GBP): NAV(s)EU:BGHSBoussard and Gavaudan Holding
06/20/20241:30AMGlobeNewswire Inc.OSE Immunotherapeutics Presents Preclinical Data on mRNA Therapeutic Platform for the Treatment of Inflammatory and Autoimmune Disorders at the FOCIS Annual Meeting, San Francisco (June 18 – 21)TG:6OPOSE Immunotherapeutics
06/20/20241:30AMGlobeNewswire Inc.BGHL (EUR): NAV(s)EU:BGHLBoussard And Gavaudan Holding Limited
06/20/20241:30AMGlobeNewswire Inc.BGHL (EUR): NAV(s)LSE:BGHLBoussard & Gavaudan Holding Limited
06/20/20241:30AMBusiness WireSensorion annonce la présentation de résultats prometteurs du SENS-401 lors de la prochaine Conférence Internationale sur les Implants Cochléaires et autres Technologies ImplantablesEU:ALSENSensorion
06/20/20241:30AMGlobeNewswire Inc.OSE Immunotherapeutics Presents Preclinical Data on mRNA Therapeutic Platform for the Treatment of Inflammatory and Autoimmune Disorders at the FOCIS Annual Meeting, San Francisco (June 18 – 21)LSE:0RADOse Immunotherapeutics Sa
06/20/20241:30AMGlobeNewswire Inc.OSE Immunotherapeutics Presents Preclinical Data on mRNA Therapeutic Platform for the Treatment of Inflammatory and Autoimmune Disorders at the FOCIS Annual Meeting, San Francisco (June 18 – 21)EU:OSEOSE Immunotherapeutics
06/20/20241:21AMAlliance NewsAlliance NewsTOP NEWS: China's central bank leaves loan prime rates unmoved
06/20/20241:15AMGlobeNewswire Inc.Basilea partners oncology drug candidate lisavanbulin with Glioblastoma Foundation
06/20/20241:00AMBusiness WireMon Courtier Energie Groupe Announces the Approval of All Resolutions Supported by the Board of Directors at its Annual General MeetingEU:ALMCEMon Courtier Energie Groupe SA
06/20/20241:00AMGlobeNewswire Inc.Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development with Cannabinoids and other Psychotropic Substances
06/20/20241:00AMGlobeNewswire Inc.Start of Day Message
06/20/20241:00AMBusiness WireMon courtier énergie groupe annonce l’approbation de l’ensemble des résolutions soutenues par le Conseil d’administration lors de son assemblée généraleEU:ALMCEMon Courtier Energie Groupe SA
06/20/20241:00AMGlobeNewswire Inc.Technip Energies awarded a significant contract for IOCL’s grassroots naphtha cracking unit at Paradip in IndiaEU:TETechnip Energies NV
06/20/20241:00AMBusiness WireDassault Systèmes’ 3DEXPERIENCE Platform on the Cloud Selected by Mahindra & Mahindra as It Accelerates Its Digital TransformationNASDAQ:DSYBig Tree Cloud Holdings Limited
06/20/20241:00AMGlobeNewswire Inc.Avextra und SynQube GmbH geben eine strategische Partnerschaft in der Arzneimittelentwicklung mit Cannabinoiden und anderen psychotropen Substanzen bekannt
06/20/20241:00AMBusiness WireBoston Partners Global Long/Short Fund Announces Transfer to FundRock Platform and Share Class Opportunity
06/20/20241:00AMGlobeNewswire Inc.Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development with Cannabinoids and other Psychotropic Substances